1. Home
  2. CTNM vs CHCT Comparison

CTNM vs CHCT Comparison

Compare CTNM & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$15.00

Market Cap

489.4M

Sector

N/A

ML Signal

HOLD

Logo Community Healthcare Trust Incorporated

CHCT

Community Healthcare Trust Incorporated

HOLD

Current Price

$18.49

Market Cap

511.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNM
CHCT
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
489.4M
511.7M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
CTNM
CHCT
Price
$15.00
$18.49
Analyst Decision
Buy
Buy
Analyst Count
4
3
Target Price
$19.00
$18.00
AVG Volume (30 Days)
417.0K
167.6K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
11.07%
EPS Growth
0.46
134.78
EPS
N/A
0.07
Revenue
N/A
$121,195,000.00
Revenue This Year
N/A
$9.06
Revenue Next Year
N/A
$8.61
P/E Ratio
N/A
$261.86
Revenue Growth
N/A
4.67
52 Week Low
$3.72
$13.23
52 Week High
$16.33
$18.39

Technical Indicators

Market Signals
Indicator
CTNM
CHCT
Relative Strength Index (RSI) 68.54 66.02
Support Level $11.82 $16.45
Resistance Level $15.60 N/A
Average True Range (ATR) 1.08 0.39
MACD 0.35 0.07
Stochastic Oscillator 88.91 98.71

Price Performance

Historical Comparison
CTNM
CHCT

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

Share on Social Networks: